| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |